Keywords: astrazeneca, reports, promising, seroquel, sr, data, schizophrenia
AstraZeneca reports promising Seroquel SR data from schizophrenia studies
Article | 26 March 2007
Anglo-Swedish drug major AstraZeneca says that data from trials of a sustained-release formulation of Seroquel (quetiapine fumarate), indicate that a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
